Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$17.3B
sum of reported positions
Reported positions
354
Changes vs prior quarter
395
84 new · 85 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 396 measured positions in 8 quarters, the typical new or larger position finished −3.9 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 985K | $470M | 2.7% | |
| 6.85M | $322M | 1.9% | |
| 959K | $321M | 1.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $13.6B | $17.3B |
| Positions | 355 | 354 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 3% |
| 4.42M |
| $267M |
| 1.5% |
| 786K | $262M | 1.5% |
| 2.8M | $249M | 1.4% |
Crinetics Pharmaceuticals Inc | 6.46M | $242M | 1.4% |
Apogee Therapeutics Inc | 1.74M | $231M | 1.3% |
| 1.53M | $230M | 1.3% |
| 6.72M | $223M | 1.3% |
| 557K | $217M | 1.3% |
| 4.73M | $192M | 1.1% |
| 497K | $189M | 1.1% |
| 1.31M | $187M | 1.1% |
| 229K | $174M | 1.0% |
| 1.77M | $171M | 1.0% |
| 6.16M | $152M | 0.9% |
| 4.43M | $148M | 0.9% |
| 1.21M | $144M | 0.8% |
| 1.56M | $142M | 0.8% |
| 517K | $141M | 0.8% |
| 227K | $140M | 0.8% |
| 4.83M | $140M | 0.8% |
| 1.99M | $138M | 0.8% |
| 355K | $134M | 0.8% |
Camtek (CAMT)
332K shares in Q1 2026
Kratos Defense & Security Solutions (KTOS)
330K shares in Q1 2026
Chord Energy (CHRD)
267K shares in Q1 2026
Ast Spacemobile (ASTS)
246K shares in Q1 2026
Lsi Industries (LYTS)
246K shares in Q1 2026
Tat Technologies (TATT)
243K shares in Q1 2026
MarketAxess (MKTX)
239K shares in Q1 2026
Patrick Industries, Inc. (PATK)
220K shares in Q1 2026
Willdan Group (WLDN)
220K shares in Q1 2026
Brinker International (EAT)
215K shares in Q1 2026
US Foods (USFD)
211K shares in Q1 2026
LeMaitre Vascular (LMAT)
197K shares in Q1 2026
JBT Marel Corporation (JBTM)
196K shares in Q1 2026
Globus Medical (GMED)
167K shares in Q1 2026
Aktis Oncology (AKTS)
150K shares in Q1 2026
Guidewire Software (GWRE)
149K shares in Q1 2026
Hasbro (HAS)
148K shares in Q1 2026
Agnico Eagle Mines (AEM)
141K shares in Q1 2026
Somnigroup International (SGI)
135K shares in Q1 2026
LCI Industries (LCII)
121K shares in Q1 2026
Dollar Tree (DLTR)
119K shares in Q1 2026
OSI Systems, Inc. (OSIS)
118K shares in Q1 2026
Advanced Drainage Systems (WMS)
106K shares in Q1 2026
Insmed (INSM)
105K shares in Q1 2026
Albemarle Corporation (ALB)
98K shares in Q1 2026
